Arturo Alegria said Vision maintains relationships with AllianceBernstein and Altment Capital, in addition to the alternatives boutiques Cheyne and Lansdowne.
Piñera cracks whip on Congress to avoid third withdrawal from AFPs
The Senate seems unlikely to pass a bill allowing AFPs to touch any additional money flowing from worker paychecks to meet pension obligations.
CCR Monthly Approval Report – February 2021
A total of eight products were added in the month from six different asset managers: Matthews, Eurizon, Allianz, JPMorgan, Genstar Capital and Valor Management.
Jorge Meyer de Pablo assumes CIO rule at Chile’s Security AGF
Jorge Meyer has replaced Gustavo Schmincke Aránguiz, who left the firm after just one year in the post.
Creuza Advisors sets sights on growth in 2021 despite AFP uncertainties
Lima-based Creuza plans to add US Equity, EM Equity, EM Debt, US Real Estate and Global PE funds to its offering, says Nicolás Lasarte, who manages the institutional business.
Global firms suffer year-ending rout as Chilean AFPs brace for second round of redemptions
The AFPs yanked USD 6.7 billion from cross-border funds and ETFs in December, mostly from equity. That brought total fund and ETF allocations to USD 89.1 billion.
CCR Monthly Approval Report – January 2021
HSBC, Aviva Investors, Dimensional, Federated Hermes, Morgan Stanles, Pictet, WisdomTree, Aberdeen Standard and, Berkshire Partners were the managers registering products in January 2021.
Cross-border funds regained lost flows from Chilean AFPs in November
The AFPs increased their exposure to equity funds by USD 4 billion, while adding USD 1.2 billion to fixed-income. The buying spree came as the S&P 500 surged 10.7%.
Felices y Forrados in the spotlight as Chilean regulators aim to limit transfers
A government proposal would limit movements between non-adjacent multifunds, while Congress will also examine the role of unregulated advisors.
CCR Monthly Approval Report – December 2020
Columbia Threadneedle led the list of registered products with 14 mutual funds, followed by Samsung with four ETFs, and Aviva, Credit Suisse and Altis each with one product approved of their own.